Betül Kalender

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation

Betül Kalender, Aytul Corapcioglu Ozdemir, Erkan Dervişoğlu et al. · International Journal of Clinical Practice · 2007 · 127 citations

Medicine, Nephrology, Dialysis +16

Association of Depression with Markers of Nutrition and Inflammation in Chronic Kidney Disease and End-Stage Renal Disease

Betül Kalender, Aytul Corapcioglu Ozdemir, Gültürk Köroğlu · Nephron Clinical Practice · 2005 · 113 citations

Medicine, Nephrology, Psychiatry +17

Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients

Meltem Özden Yüce, Hale Maral Kır, Derya Akaydın et al. · Clinical Biochemistry · 2002 · 94 citations

Medicine, Biochemistry, Nephrology +17

Serum cystatin C level as a potentially good marker for impaired kidney function

Hafize Uzun, Melek Ozmen Keles, Rezzan Ataman et al. · Clinical Biochemistry · 2005 · 52 citations

Medicine, Nephrology, Clinical Biochemistry +14